We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.

For more information visit our privacy policy.

Common Contracts

2 similar License Agreement contracts by Recro Pharma, Inc.

NON-INJECTABLE DEXMEDETOMIDINE LICENSE AGREEMENT between RECRO PHARMA, INC. and ORION CORPORATION DATED AS OF AUGUST 22, 2008
License Agreement • November 29th, 2013 • Recro Pharma, Inc. • Pharmaceutical preparations

Standard Contracts

Free NDA TemplateoneNDA-badgeFree SaaS TemplateoneSaaS-badge
EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [* * *] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. FADOLMIDINE LICENSE AGREEMENT
License Agreement • November 29th, 2013 • Recro Pharma, Inc. • Pharmaceutical preparations

paid to Orion; if such court rules (or, in the event the ruling can be appealed against, upon the final ruling of the relevant appellate court(s)) that the Orion Patent at issue is invalid, unenforceable, or will not be infringed by the Generic Product or other finding permitting the Generic Product to be marketed and sold, the funds in escrow shall be returned to Licensee.